Announcements
- Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
- Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
- MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
- MESA LABS DECLARES QUARTERLY DIVIDEND
- Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
- Mesa Labs Releases Second Annual Responsible Business Program Brochure
- Mesa Laboratories Appoints Mark Capone to its Board of Directors
- Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
- Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
- Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
More ▼
Key statistics
As of last trade Mesa Laboratories Inc (MLI:DUS) traded at 82.50, 6.45% above its 52-week low of 77.50, set on Jun 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 82.00 |
---|---|
High | 82.50 |
Low | 82.00 |
Bid | 82.00 |
Offer | 85.00 |
Previous close | 82.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 5.41m |
Free float | 5.13m |
P/E (TTM) | -- |
Market cap | 489.08m USD |
EPS (TTM) | -47.15 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 11:31 BST.
More ▼